The impact of statins on melanoma survival: a systematic review and meta-analysis

2024-9-12

Treatment outcomes following partial shave biopsy of atypical and malignant melanocytic tumors in pediatric patients

2024-9-5

Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting

2024-8-30

Pediatric melanoma incidence and survival: a fifteen-year nationwide retrospective cohort study in Korea (2004–2019)

2024-8-30

The death rate for melanoma remained unchanged in the USA during the coronavirus disease 2019 pandemic

2024-8-28

Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma: Erratum

2024-8-28

Transcutaneous sentinel lymph node detection in skin melanoma with near-infrared fluorescence imaging using indocyanine green

2024-8-2

Development and validation of prognostic nomogram in pediatric melanoma: a population-based study

2024-7-31

Exacerbation of Kaposi sarcoma following BRAF/MEK inhibitor therapy in a melanoma patient: a case report and mechanistic insight

2024-7-22

Hemophagocytic lymphohistiocytosis induced by dabrafenib-trametinib in a patient with metastatic melanoma: a case report and pharmacovigilance analysis

2024-7-22

Real-world use and outcomes of targeted therapy and immunotherapy for adjuvant treatment of BRAF-mutated melanoma patients in the United States

2024-7-16

Interfering with aggregated α-synuclein in advanced melanoma leads to a major upregulation of MHC class II proteins

2024-7-2

Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1–resistant mucosal melanoma

2024-6-28

A retrospective study of clinicopathological and prognostic characteristics in 177 Chinese patients with acral melanoma: heterogeneity based on tumor site

2024-6-26

Synchronous double primary vulvar melanoma: a not so rare possibility. A clinical and dermoscopic case study

2024-6-24

Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy

2024-6-24

Long-term outcomes and patterns of recurrence in patients with thin melanoma and a negative sentinel lymph node biopsy: a single-center experience

2024-6-14

Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model

2024-6-7

Reflectance confocal microscopy versus dermoscopy for the diagnosis of cutaneous melanoma: a head-to-head comparative meta-analysis

2024-6-7

Causal relationship between sex hormones and cutaneous melanoma: a two-sample Mendelian randomized study

2024-6-5

Head and neck melanoma: the eyelid region has a better prognosis and easier management: a retrospective survey and systematic review

2024-6-3

The number needed to biopsy for cutaneous melanoma in academic dermatology clinics

2024-5-28

Sex-dependent interaction of PTGS2 with miR-146a as risk factor for melanoma and the impact of sex hormones in gene expression in skin cells

2024-5-28

Relationships between survival and real-world recurrence-free survival or distant metastasis-free survival among patients with completely resected stage IIB or IIC melanoma

2024-5-27

Regorafenib in patients with pretreated advanced melanoma: a single-center case series

2024-5-27

Cytomegalovirus gastritis as a rare adverse event during combined ipilimumab and nivolumab in a patient with melanoma

2024-5-20

Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma

2024-5-20

Influence of regression, its extent and tumor-infiltrating lymphocytes on sentinel node status, relapse, and survival in a 10-year retrospective study of melanoma patients

2024-5-13

Tocilizumab in the treatment of steroid refractory immune-related hepatotoxicity: a case series and review of the literature

2024-4-29

The effect of COVID-19 on early melanoma detection

2024-4-24

Pretreatment CD8+PD-1+ to CD4+PD-1+ ratio is associated with the prognosis of advanced melanoma patients treated with PD-1 inhibitors

2024-4-22

Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition

2024-4-18

Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanoma

2024-4-5

Intracranial hemorrhage caused by dabrafenib and trametinib therapy for metastatic melanoma

2024-4-5

Assessing melanoma prognosis: the interplay between patient profiles, survival, and BRAF, NRAS, KIT, and TWT mutations in a retrospective multi-study analysis

2024-3-29

Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey

2024-3-28

Feasibility and efficacy of indocyanine green in monitoring systemic drug leakage during isolated limb perfusion for recurrent melanoma of extremity

2024-3-15

Retrospective comparison of a weight-based dose every 2 weeks with a fixed dose every month: a real-life analysis of nivolumab in the treatment of advanced melanoma

2024-3-15

Genetic causal relationship between gut microbiota and cutaneous melanoma: a two-sample Mendelian randomization study

2024-3-11

What matters most to people with metastatic uveal melanoma? A qualitative study to inform future measurement of health-related quality of life

2024-3-5

Global trends in cutaneous malignant melanoma incidence and mortality

2024-2-21

Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy

2024-2-16

Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma

2024-2-16

Clinical and genetic determinants of vitamin D receptor expression in cutaneous melanoma patients

2024-2-13

Neonatal cutaneous melanoma with cutaneous metastasis: a case report and review of literature

2024-2-7

Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practice

2024-2-7

Hypoxic transcriptomes predict survival and tumor-infiltrating immune cell composition in cutaneous melanoma

2024-2-7

Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020

2024-1-23

Simultaneous melanomas in the setting of multiple primary melanomas

2024-1-15

The effect of microRNA-9 overexpression on inhibition of melanoma cancer stem cells tumorigenicity

2024-1-15